Sarepta Therapeutics, Inc. (SRPT)
17.24
-0.58
(-3.28%)
USD |
NASDAQ |
Nov 09, 16:00
17.45
+0.22
(+1.25%)
After-Hours: 19:36
Sarepta Therapeutics Total Return Level : 17.82 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 17.82 |
| November 05, 2026 | 17.57 |
| November 04, 2026 | 18.99 |
| November 03, 2026 | 18.54 |
| November 02, 2026 | 18.32 |
| October 30, 2026 | 18.62 |
| October 29, 2026 | 19.23 |
| October 28, 2026 | 19.32 |
| October 27, 2026 | 18.89 |
| October 26, 2026 | 17.98 |
| October 23, 2026 | 17.73 |
| October 22, 2026 | 18.18 |
| October 21, 2026 | 18.56 |
| October 20, 2026 | 19.17 |
| October 19, 2026 | 17.73 |
| October 16, 2026 | 17.10 |
| October 15, 2026 | 17.79 |
| October 14, 2026 | 16.83 |
| October 13, 2026 | 16.51 |
| October 12, 2026 | 17.44 |
| October 09, 2026 | 17.85 |
| October 08, 2026 | 18.21 |
| October 07, 2026 | 17.50 |
| October 06, 2026 | 17.31 |
| October 05, 2026 | 17.49 |
| Date | Value |
|---|---|
| October 02, 2026 | 17.50 |
| October 01, 2026 | 17.57 |
| September 30, 2026 | 18.22 |
| September 29, 2026 | 18.64 |
| September 28, 2026 | 18.80 |
| September 25, 2026 | 18.67 |
| September 24, 2026 | 18.39 |
| September 23, 2026 | 18.95 |
| September 22, 2026 | 20.81 |
| September 21, 2026 | 20.14 |
| September 18, 2026 | 20.11 |
| September 17, 2026 | 20.67 |
| September 16, 2026 | 19.76 |
| September 15, 2026 | 20.72 |
| September 14, 2026 | 20.92 |
| September 11, 2026 | 20.45 |
| September 10, 2026 | 20.52 |
| September 09, 2026 | 22.02 |
| September 08, 2026 | 20.94 |
| September 04, 2026 | 22.50 |
| September 03, 2026 | 22.99 |
| September 02, 2026 | 23.21 |
| September 01, 2026 | 21.33 |
| August 31, 2026 | 21.03 |
| August 28, 2026 | 20.86 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Beam Therapeutics, Inc. | 26.41 |
| Moderna, Inc. | 254.19 |
| Rocket Pharmaceuticals, Inc. | 2.385 |
| Intellia Therapeutics, Inc. | 11.35 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |